Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer

Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer

ABSTRACT Background Triple‐negative breast cancer (TNBC) is a heterogeneous disease characterized by high aggressiveness, high malignancy, and poor prognosis compared to other breast cancer subtypes. Objective This review aims to explore recent advances in understanding TNBC and to provide new insig...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuhan Liu, Yuhan Zou, Yangli Ye, Yong Chen
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Cancer Medicine
Subjects:	classification drug resistance genomic alterations signaling pathways triple‐negative breast cancer
Online Access:	https://doi.org/10.1002/cam4.70410
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis of Zinc Oxide-Doped Carbon Dots for Treatment of Triple-Negative Breast Cancer
by: Wang M, et al.
Published: (2024-12-01)

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
by: Lucía Serrano García, et al.
Published: (2024-12-01)

Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
by: Sisi Gong, et al.
Published: (2024-11-01)

Classifications of triple-negative breast cancer: insights and current therapeutic approaches
by: Ziqi Chen, et al.
Published: (2025-02-01)

Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer
by: Yuqin Lin, et al.
Published: (2023-12-01)

Function of vasohibin-2 and the mechanism of alternative splicing in triple-negative breast cancer
by: WANG Wei, et al.
Published: (2024-12-01)

Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
by: Desh Deepak Singh, et al.
Published: (2024-12-01)

Unveiling the Mechanisms and Therapeutic Effects of Xiaoyao Sanjie Decoction in Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Approach
by: Qi Y, et al.
Published: (2024-12-01)

NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer
by: Payton De La Cruz, et al.
Published: (2024-12-01)

DLAT promotes triple-negative breast cancer progression via YAP1 activation
by: Diya Liu, et al.
Published: (2024-12-01)

Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
by: Chang Cheng, et al.
Published: (2025-01-01)

RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
by: Jialin Yuan, et al.
Published: (2025-01-01)

Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer
by: Jia-xin Qiao, et al.
Published: (2024-12-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

Low-intensity pulsed ultrasound combined with microbubble mediated JNK/c-Jun pathway to reverse multidrug resistance in triple-negative breast cancer
by: Nina Qu, et al.
Published: (2024-11-01)

Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
by: Ahmet Necati Sanli, et al.
Published: (2024-04-01)

SPP1 mRNA Expression Is Associated with M2 Macrophage Infiltration and Poor Prognosis in Triple-Negative Breast Cancer
by: Yu-Chia Chen, et al.
Published: (2024-11-01)

Triple-negative breast cancer patients treated with subcutaneous mastectomy with immediate reconstruction: single institution experience
by: Artur Bocian, et al.
Published: (2024-12-01)

Self-propelling, protein-bound magnetic nanobots for efficient in vitro drug delivery in triple negative breast cancer cells
by: Neha Naikwadi, et al.
Published: (2024-12-01)

Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01)

Triple-negative ectopic breast cancer of the male scrotum: a case report
by: Yuhui Nie, et al.
Published: (2024-12-01)

The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer
by: Jie Zhu, et al.
Published: (2025-02-01)

Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition
by: Danxiang Chen, et al.
Published: (2024-12-01)

Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
by: Ruiliang Chen, et al.
Published: (2024-12-01)

Deep Learning and Radiomics in Triple-Negative Breast Cancer: Predicting Long-Term Prognosis and Clinical Outcomes
by: Cheng C, et al.
Published: (2025-01-01)

Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function
by: Annat Raiter, et al.
Published: (2025-02-01)

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
by: Wei Chen, et al.
Published: (2025-01-01)

Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine
by: Saif Khan, et al.
Published: (2024-12-01)

Role of Harmaline in Inhibiting c-Myc, Altering Molecular Typing, and Promoting Apoptosis in Triple-Negative Breast Cancer
by: Xu H, et al.
Published: (2024-12-01)

The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
by: Yao Yi, et al.
Published: (2025-01-01)

The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
by: Huayan Gu, et al.
Published: (2025-02-01)

B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
by: Nicole J. Toney, et al.
Published: (2025-01-01)

Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
by: Haiyan Zhang, et al.
Published: (2024-12-01)

Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-03-01)

Investigating the therapeutic effect of folic acid conjugated ZnO nanoparticles on human triple negative breast cancer cell line
by: Shiva Sabzandam, et al.
Published: (2023-06-01)

Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors
by: Nevena Ilieva, et al.
Published: (2024-11-01)

Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
by: Maximilian Marhold, et al.
Published: (2023-12-01)

Galangin promotes apoptosis by upregulating the pro-apoptotic gene BAX in triple-negative breast cancer
by: Shruti Sinnarkar, et al.
Published: (2024-12-01)

Amine-Terminated Silver Nanoparticles Exhibit Potential for Selective Targeting of Triple-Negative Breast Cancer
by: Jayshree H. Ahire, et al.
Published: (2024-10-01)

Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
by: Sarah Talamantes, et al.
Published: (2020-10-01)